$INSM has been mentioned 18 times over the past 12 months by 5 distinct FinTwit voices, with the conversation centered primarily in the biotech sector. Adam Feuerstein (@adamfeuerstein) accounts for 14 of these mentions, establishing him as the dominant voice discussing Insmed. The first mention appeared on September 2, 2025, and the most recent activity occurred on July 6, 2026. The other four voices—@ftr_investors, @investmentguru_, @unusual_whales, and @yasutaketin—each contributed one mention during this period.

Recent discussions of $INSM have focused on index composition changes and comparative biotech performance. In June 2026, multiple voices noted that Nasdaq announced $INSM's removal from the Nasdaq-100 index effective June 22, 2026, as part of a quarterly rebalance. Feuerstein's most recent mention on July 6, 2026, placed $INSM among underperforming biotech companies, comparing its performance trajectory to other names including $CRNX, $MDGL, $ALNY, and $BBIO.